Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
Celcuity Teams Up With MD Anderson, Novartis, Puma Biotech To Study New Drug Regimen In Breast Cancer
Annovis Bio Stock Is Trading Higher After Parkinson's Med Shows Improvement In Speed, Coordination
Adamis Pharma's Tempol Decreases COVID-19 Related Lung Inflammation In Animal Studies
Phase 2 Clinical Trial Recent News
Clene's Lead Candidate Shows Improvement In Functional Scores In Multiple Sclerosis Studies
Ayala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue Tumors
Verona Pharma's pMDI Ensifentrine Shows Improved Lung Function In Mid-Stage COPD Study
Synthetic Biologics Surges 25% Amid Positive Phase 2 Data